Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-11
Closed -$2.29K 934
2022
Q4
$2.29K Buy
11
+9
+450% +$1.98K ﹤0.01% 665
2022
Q3
$0 Hold
2
﹤0.01% 985
2022
Q2
$0 Sell
2
-15
-88% -$3.19K ﹤0.01% 975
2022
Q1
$4K Hold
17
﹤0.01% 544
2021
Q4
$4K Sell
17
-1
-6% -$259 ﹤0.01% 639
2021
Q3
$5K Hold
18
﹤0.01% 496
2021
Q2
$4K Buy
+18
New +$3.78K ﹤0.01% 486

Other funds holding RMD

Lee Financial's RMD Position: Q1 2023 in Review

Lee Financial sold out of ResMed (RMD) in Q1 2023, closing a stake of 11 shares — an estimated $2.29K sold.

Lee Financial first reported a position in RMD in Q2 2021 and held it in 7 quarters. The position peaked at $5K in Q3 2021. 676 funds tracked by Wall St. Rank hold RMD as of Q1 2023.

  • Lee Financial reported no remaining ResMed position as of Q1 2023 after selling out during the quarter.
  • Lee Financial sold 11 ResMed shares in Q1 2023, an estimated $2.29K.
  • Lee Financial first reported a position in ResMed in Q2 2021 and held it in 7 quarters.
  • Lee Financial's ResMed position peaked at $5K in Q3 2021.
  • 676 funds tracked by Wall St. Rank held ResMed as of Q1 2023.

Based on Lee Financial's 13F filing for Q1 2023, filed 15 May 2023.